いぼの治療の世界市場レポート 2024

いぼの治療の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には3.7%の年間複合成長率（CAGR）で22億9,000万米ドルに成長すると予想されます。いぼの治療の予測期間における予想される成長は、HPVに対する精密医療の適用、レーザー治療の革新、併用療法の探求、デジタルヘルスソリューションの統合、ヘルスケアの改善を目的とした取り組みなど、さまざまな要因によるものと考えられます。予測期間中に予想される主な動向には、標的抗ウイルス療法の開発、遺伝子編集における進行中の調査、生分解性送達システムの使用、精神皮膚科学への焦点、いぼ治療分野におけるその他の革新的なアプローチが含まれます。

いぼの治療市場は、いぼのワクチン接種がますます重視されることにより成長すると予想されています。ワクチン接種には、感染症、特にヒトパピローマウイルス（HPV）によって引き起こされるいぼに対する抗体を生成するワクチンの導入が含まれます。 HPVに対する治療用または予防用ワクチンは、いぼの形成を防ぐ上で重要な役割を果たします。 2023年7月に世界保健機関が報告したように、ワクチン接種への注目は前向きな傾向をもたらしており、ゼロ接種の小児が2021年の1,810万人から2022年には1,430万人に減少することが示されています。さらに、ワクチンの初回接種が世界的にカバーされています。女児のHPVワクチン接種率は2021年の16％から2022年には21％に増加し、いぼの治療市場の成長を牽引しました。

いぼの治療市場の成長は、ヘルスケアサービスへのアクセスの向上によって促進されると予想されます。医療ケアと治療を含むヘルスケアサービスでは、HPVに起因する一般的な皮膚症状に対処するためにいぼの治療が利用されています。これらの治療法は、症状を軽減し、治癒を促進し、いぼの拡大を防ぎ、全体的な健康に貢献することを目的としています。特に、2023年の経済協力開発機構（OECD）によると、OECD諸国のヘルスケア支出は2021年のGDPの9.7％を占め、2020年の9.6％からの上昇を反映しています。このヘルスケアサービスへのアクセスの向上は、いぼの治療市場の主要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のいぼの治療市場促進要因と制約
  • 市場の促進要因
  • 市場の抑制要因
• 世界のいぼの治療市場規模実績と成長、2018年から2023年
• 世界いぼの治療の市場規模と成長予測、2023年から2028年、2033年

第6章 市場セグメンテーション

• 世界のいぼの治療市場、種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 尋常性疣贅
• 性器いぼ
• 扁平疣贅
• その他のタイプ
• 世界のいぼの治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 物理的破壊
• 免疫調節
• 化学的破壊
• 世界のいぼの治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のいぼの治療市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のいぼの治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• いぼの治療市場の競合情勢
• いぼの治療市場の企業プロファイル
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Merck &Co. Inc.
  • Verrica Pharmaceuticals Inc.
  • Bausch Health Companies Inc.

第31章 その他の大手および革新的な企業

• Dr. Reddy's Laboratories Ltd
• Cipla Inc.
• Prestige Consumer Healthcare Inc.
• Maruho Co. Ltd
• Taro Pharmaceutical Industries Ltd
• Aclaris Therapeutics Inc.
• Novan Inc
• Scholl's Wellness Co
• Orgenesis
• AIM ImmunoTech Inc
• Nielsen BioSciences Inc
• KinoPharma Inc.
• pHion Therapeutics
• RXi Pharmaceuticals
• Phio Pharmaceuticals Corp.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Wart therapeutics refer to medical drugs and treatments designed to exert therapeutic effects in addressing the skin condition known as warts, caused by the human papillomavirus (HPV). These therapeutics are utilized for the treatment of various wart types affecting the hands, face, and feet.

The primary types of warts in wart therapeutics include common warts, genital warts, flat warts, and others. Common warts are small, raised skin growths typically found on the hands or fingers. Treatment approaches for common warts involve physical destruction, immunomodulation, and chemical destruction. Wart therapeutics are employed in diverse healthcare settings, including hospitals, homecare, specialty clinics, and others.

The warts therapeutics market research report is one of a series of new reports from The Business Research Company that provides warts therapeutics market statistics, including the warts therapeutics industry global market size, regional shares, competitors with an warts therapeutics market share, detailed warts therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the warts therapeutics industry. This warts therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The warts therapeutics market size has grown steadily in recent years. It will grow from $1.91 billion in 2023 to $1.98 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth observed in the historic period can be attributed to various factors, including the use of salicylic acid, the development of cryotherapy, the evolution of topical treatments, surgical interventions, and the emergence of immunotherapy. These advancements and treatment modalities contributed to the historical growth of wart therapeutics.

The warts therapeutics market size is expected to see steady growth in the next few years. It will grow to $2.29 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The anticipated growth in the forecast period for wart therapeutics can be attributed to various factors, including the application of precision medicine for HPV, innovations in laser therapy, the exploration of combination therapies, the integration of digital health solutions, and initiatives aimed at improving healthcare accessibility. Key trends expected during the forecast period include the development of targeted antiviral therapies, ongoing research in gene editing, the use of biodegradable delivery systems, a focus on psychodermatology, and other innovative approaches in the field of wart therapeutics.

The wart therapeutics market is anticipated to experience growth, driven by the increasing emphasis on vaccinations for warts. Vaccination involves introducing a vaccine to develop antibodies against infections, particularly warts caused by the human papillomavirus (HPV). Therapeutic or prophylactic vaccines against HPV play a crucial role in preventing wart formation. The focus on vaccinations has led to a positive trend, as reported by the World Health Organization in July 2023, indicating a reduction in zero-dose children from 18.1 million in 2021 to 14.3 million in 2022. Furthermore, global coverage for the initial dose of the HPV vaccine in girls increased from 16% in 2021 to 21% in 2022, driving the growth of the wart therapeutics market.

The growth of the wart therapeutics market is expected to be fueled by increased accessibility to healthcare services. Healthcare services, encompassing medical care and treatment, utilize wart therapeutics to address common skin conditions resulting from HPV. These treatments aim to alleviate symptoms, promote healing, and prevent the spread of warts, contributing to overall well-being. Notably, according to the Organization for Economic Co-operation and Development (OECD) in 2023, healthcare spending in OECD countries accounted for 9.7% of GDP in 2021, reflecting a rise from 9.6% in 2020. This increased accessibility to healthcare services is a key driver of the wart therapeutics market.

A significant trend in the wart therapeutics market is the focus on product innovation by companies striving to maintain a competitive edge. Verrica Pharmaceuticals Inc., a US-based dermatology therapeutics company, exemplifies this trend with its announcement in February 2023. The FDA accepted the resubmitted New Drug Application (NDA) for VP-102, a drug-device combination product delivering cantharidin for precise topical dosing and targeted administration to treat molluscum contagiosum, a type of wart.

Major companies in the wart therapeutics market are engaging in strategic partnerships to support clinical trials and advance research. Vial, a US-based pharmaceuticals company, partnered with Nielsen BioSciences Inc. in June 2023 to study the safety and efficacy of CANDIN for treating common warts. This collaborative approach aims to contribute to the development of new therapies and devices for wart treatment.

In January 2021, Iwaki Seiyaku Co., Ltd., a Japan-based pharmaceutical company, acquired new shares in KinoPharma Inc., focusing on developing drug formulations for wart treatment caused by HPV. This strategic partnership enhances the supply chain of active pharmaceutical ingredients (APIs) for antiviral drugs, particularly within the dermatology sector. KinoPharma, Inc. is a Japan-based therapeutics company specializing in warts caused by HPV.

Major companies operating in the warts therapeutics market report are Pfizer Inc., GlaxoSmithKline PLC, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd., Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Taro Pharmaceutical Industries Ltd., Aclaris Therapeutics Inc., Novan Inc., Scholl's Wellness Co, Orgenesis, AIM ImmunoTech Inc., Nielsen BioSciences Inc., KinoPharma Inc., pHion Therapeutics, RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, Compound W, Duofilm, Curad Mediplast, Euro Vital Pharma GmbH, Koninklijke Utermohlen NV

North America was the largest region in the warts therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the warts therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The warts therapeutics market consists of sales of therapeutic drugs such as 5-fluorouracil, benzalkonium, glutaraldehyde, cryotherapy, or podophyllin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Warts Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on warts therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for warts therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The warts therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Common Warts; Genital Warts; Flat Warts; Other Types
• 2) By Treatment: Physical Destruction; Immunomodulation; Chemical Destruction
• 3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; GlaxoSmithKline plc; Merck & Co. Inc.; Verrica Pharmaceuticals Inc.; Bausch Health Companies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Warts Therapeutics Market Characteristics

3. Warts Therapeutics Market Trends And Strategies

4. Warts Therapeutics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Warts Therapeutics Market Size and Growth

• 5.1. Global Warts Therapeutics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Warts Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Warts Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Warts Therapeutics Market Segmentation

• 6.1. Global Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Common Warts
• Genital Warts
• Flat Warts
• Other Types
• 6.2. Global Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Physical Destruction
• Immunomodulation
• Chemical Destruction
• 6.3. Global Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users

7. Warts Therapeutics Market Regional And Country Analysis

• 7.1. Global Warts Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Warts Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Warts Therapeutics Market

• 8.1. Asia-Pacific Warts Therapeutics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Warts Therapeutics Market

• 9.1. China Warts Therapeutics Market Overview
• 9.2. China Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Warts Therapeutics Market

• 10.1. India Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Warts Therapeutics Market

• 11.1. Japan Warts Therapeutics Market Overview
• 11.2. Japan Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Warts Therapeutics Market

• 12.1. Australia Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Warts Therapeutics Market

• 13.1. Indonesia Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Warts Therapeutics Market

• 14.1. South Korea Warts Therapeutics Market Overview
• 14.2. South Korea Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Warts Therapeutics Market

• 15.1. Western Europe Warts Therapeutics Market Overview
• 15.2. Western Europe Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Warts Therapeutics Market

• 16.1. UK Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Warts Therapeutics Market

• 17.1. Germany Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Warts Therapeutics Market

• 18.1. France Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Warts Therapeutics Market

• 19.1. Italy Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Warts Therapeutics Market

• 20.1. Spain Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Warts Therapeutics Market

• 21.1. Eastern Europe Warts Therapeutics Market Overview
• 21.2. Eastern Europe Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Warts Therapeutics Market

• 22.1. Russia Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Warts Therapeutics Market

• 23.1. North America Warts Therapeutics Market Overview
• 23.2. North America Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Warts Therapeutics Market

• 24.1. USA Warts Therapeutics Market Overview
• 24.2. USA Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Warts Therapeutics Market

• 25.1. Canada Warts Therapeutics Market Overview
• 25.2. Canada Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Warts Therapeutics Market

• 26.1. South America Warts Therapeutics Market Overview
• 26.2. South America Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Warts Therapeutics Market

• 27.1. Brazil Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Warts Therapeutics Market

• 28.1. Middle East Warts Therapeutics Market Overview
• 28.2. Middle East Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Warts Therapeutics Market

• 29.1. Africa Warts Therapeutics Market Overview
• 29.2. Africa Warts Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Warts Therapeutics Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Warts Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Warts Therapeutics Market Competitive Landscape And Company Profiles

• 30.1. Warts Therapeutics Market Competitive Landscape
• 30.2. Warts Therapeutics Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. GlaxoSmithKline plc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Verrica Pharmaceuticals Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bausch Health Companies Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Warts Therapeutics Market Other Major And Innovative Companies

• 31.1. Dr. Reddy's Laboratories Ltd
• 31.2. Cipla Inc.
• 31.3. Prestige Consumer Healthcare Inc.
• 31.4. Maruho Co. Ltd
• 31.5. Taro Pharmaceutical Industries Ltd
• 31.6. Aclaris Therapeutics Inc.
• 31.7. Novan Inc
• 31.8. Scholl's Wellness Co
• 31.9. Orgenesis
• 31.10. AIM ImmunoTech Inc
• 31.11. Nielsen BioSciences Inc
• 31.12. KinoPharma Inc.
• 31.13. pHion Therapeutics
• 31.14. RXi Pharmaceuticals
• 31.15. Phio Pharmaceuticals Corp.

32. Global Warts Therapeutics Market Competitive Benchmarking

33. Global Warts Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Warts Therapeutics Market

35. Warts Therapeutics Market Future Outlook and Potential Analysis

• 35.1 Warts Therapeutics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Warts Therapeutics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Warts Therapeutics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer